APA

Stavenhagen J. B., Gorlatov S., Tuaillon N., Rankin C. T., Li H., Burke S., Huang L., Vijh S., Johnson S., Bonvini E. & Koenig S. (20071127). Fc optimization of therapeutic antibodies enhances their ability to kill tumor cells in vitro and controls tumor expansion in vivo via low-affinity activating Fcgamma receptors. : Cancer research.

Chicago

Stavenhagen Jeffrey B, Gorlatov Sergey, Tuaillon Nadine, Rankin Christopher T, Li Hua, Burke Stephen, Huang Ling, Vijh Sujata, Johnson Syd, Bonvini Ezio and Koenig Scott. 20071127. Fc optimization of therapeutic antibodies enhances their ability to kill tumor cells in vitro and controls tumor expansion in vivo via low-affinity activating Fcgamma receptors. : Cancer research.

Harvard

Stavenhagen J. B., Gorlatov S., Tuaillon N., Rankin C. T., Li H., Burke S., Huang L., Vijh S., Johnson S., Bonvini E. and Koenig S. (20071127). Fc optimization of therapeutic antibodies enhances their ability to kill tumor cells in vitro and controls tumor expansion in vivo via low-affinity activating Fcgamma receptors. : Cancer research.

MLA

Stavenhagen Jeffrey B, Gorlatov Sergey, Tuaillon Nadine, Rankin Christopher T, Li Hua, Burke Stephen, Huang Ling, Vijh Sujata, Johnson Syd, Bonvini Ezio and Koenig Scott. Fc optimization of therapeutic antibodies enhances their ability to kill tumor cells in vitro and controls tumor expansion in vivo via low-affinity activating Fcgamma receptors. : Cancer research. 20071127.